This guide covers what the research actually shows about BPC-157, what its used for at BHRC, and what an honest clinical picture of the compound looks like including where the evidence is strong and where it still has gaps
Studies examining supplement quality find contamination rates of 12-58% in ergogenic supplements, with 30% containing incorrect amino acid sequences and 65% exceeding safe endotoxin thresholds
Rat Achilles tendon transection studies demonstrate that BPC-157-treated tendons achieve mechanical integrity scores at 14 days post-injury that untreated tendons do not reach until 21 to 28 days, representing a compression of the healing timeline by 7 to 14 days in the rodent model
The "Typical dose" column lists the dose most commonly cited in community protocols
The Global Response Assessment Questionnaire was utilized to evaluate the patients perception of the effectiveness of this therapy and all 12 patients responded with a score corresponding to significant improvement
And as with all things in this space, source quality matters